Stockreport

CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF CRSP announced its decision to discontinue the development of first-generation allogeneic CAR T product candidates, CTX110 (targeting CD19) and CTX130 (targeting CD70). [Read more]